$0.00
(+0.00%
) Quote detailsUSD
+$0.00
(+0.00%
)At Close (As of Nov 5, 2025)
$1.14B
Market Cap
31.84
P/E Ratio
0.57
EPS
$22.00
52 Week High
$16.52
52 Week Low
HEALTHCARE
Sector
| Field | Value |
|---|---|
| Ex Dividend Date | 2015-09-08 |
| Declaration Date | None |
| Record Date | None |
| Payment Date | None |
| Amount | 0.25 |
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
Innoviva, Inc. is a biopharmaceutical company headquartered in Burlingame, California, specializing in the development and commercialization of innovative therapies targeting respiratory diseases. The company leverages proprietary technologies and strategic collaborations with leading healthcare partners to create advanced treatment solutions that significantly enhance patient outcomes. With a diverse and robust pipeline, Innoviva is dedicated to addressing pressing unmet medical needs and advancing the frontiers of respiratory healthcare, underscoring its commitment to improving the quality of life for patients.
ASST
NVDA
BYND
VHAI
PFE
SNAP
PLUG
TSLA
GRAB
F
PLTR
INTC
DNN
AMD
T
AAL
BITF
KVUE
CIFR
RXRX
SOFI
TEVA
SMCI
BAC
ADAP
NFE
AMCR
WBD
IREN
MARA
QS
VALE
DVLT
CAN
RIG
RGTI
U
WULF
FUBO
NVO
EPWK
BTBT
TLRY
NCLH
JOBY
RIOT
HIMS
NOK
APPS
CMG
HTZ
ALIT
HOOD
QBTS
KDLY
GOOGL
NIO
BW
NVTS
MU
HPE
AG
CPNG
HBAN
PBR
ITUB
PCG
MSPR
ASST
NVDA
BYND
VHAI
PFE
SNAP
PLUG
TSLA
GRAB
F
PLTR
INTC
DNN
AMD
T
AAL
BITF
KVUE
CIFR
RXRX
SOFI
TEVA
SMCI
BAC
ADAP
NFE
AMCR
WBD
IREN
MARA
QS
VALE
DVLT
CAN
RIG
RGTI
U
WULF
FUBO
NVO
EPWK
BTBT
TLRY
NCLH
JOBY
RIOT
HIMS
NOK
APPS
CMG
HTZ
ALIT
HOOD
QBTS
KDLY
GOOGL
NIO
BW
NVTS
MU
HPE
AG
CPNG
HBAN
PBR
ITUB
PCG
MSPR